Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist-Reference-Cited by-同舟云学术

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist

Published:2014-10-16 Issue:6 Volume:465 Page:623-628
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Montironi Rodolfo,Hammond Elizabeth H.,Lin Daniel W.,Gore John L.,Srigley John R.,Samaratunga Hema,Egevad Lars,Rubin Mark A.,Nacey John,Klotz Laurence,Sandler Howard,Zietman Anthony L.,Holden Stuart,Humphrey Peter A.,Evans Andrew J.,Delahunt Brett,McKenney Jesse K.,Berney Daniel,Wheeler Thomas M.,Chinnaiyan Arul,True Lawrence,Knudsen Beatrice,Epstein Jonathan I.,Amin Mahul B.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00428-014-1668-5.pdf

Reference25 articles.

1. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR, Investigators CPSURE (2004) The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 171:1393–1401

2. Albertsen PC, Hanley JA, Fine J (2005) 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA 293:2095–2101

3. Cooperberg MR, Broering JM, Carroll PR (2010) Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 28:1117–1123

4. Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT (2009) Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol 27:4300–4305

5. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ (2002) Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94:981–990

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: systematic review;Journal of Clinical Epidemiology;2024-05

2. Artificial intelligence–assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies;Virchows Archiv;2023-02-21

3. Prevalence of prostate cancer in PI-RADS version 2.1 T2-weighted transition zone ‘nodule in nodule’ and ‘homogeneous mildly hypointense area between nodules’ criteria: MRI-radical prostatectomy histopathological evaluation;European Radiology;2021-03-29

4. An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy;Modern Pathology;2021-03-29

5. Histopathological variant types diagnosed in prostate surgery;annals of urologic oncology;2020-12-31